terconazole has been researched along with Candidiasis, Vulvovaginal in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (54.29) | 18.7374 |
| 1990's | 12 (34.29) | 18.2507 |
| 2000's | 3 (8.57) | 29.6817 |
| 2010's | 1 (2.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heeres, J; Hendrickx, R; Van Cutsem, J | 1 |
| Fan, S; Li, T; Liang, Y; Liu, X; Xu, H; Zhu, Y | 1 |
| Janssen, PA; Van Cutsem, J; Van Gerven, F; Zaman, R | 1 |
| Mummaw, NL; Schooley, SL; Stein, GE | 1 |
| Lin, AN; Searles, GE; Tredget, EE | 1 |
| Cruz Talonia, F; García Figueroa, RG; Ramírez Palacios, D; Romero Cabello, R; Sauceda, L | 1 |
| Ringdahl, EN | 1 |
| Chatwani, A; Nyirjesy, P; Sood, G; Weitz, MV | 1 |
| Benrubi, GI; Griffin, CR; Magee, MJ; Parker, R; Slavin, MB | 1 |
| Giaquinta, D; Horowitz, BJ; Ito, S | 1 |
| Corson, SL; Kapikian, RR; Nehring, R | 1 |
| Van Cutsem, J | 1 |
| Arguelles Domenzain, P; Carrión Tizcareño, H; Llaca Rodríguez, V | 2 |
| Cepický, P; Sosnová, K; Týcová, H; Zwinger, A | 1 |
| Doering, PL; Santiago, TM | 1 |
| Broekhuizen, FF; Gelbart, SM; Gotwalt, KT; Kellett, AV; Scaglione, NJ; Thomason, JL | 1 |
| Meriwether, C; Schmitt, C; Sobel, J | 1 |
| Moebius, UM | 1 |
| Kjaeldgaard, A | 1 |
| Martinek, G | 1 |
| Delecour, M | 1 |
| Nahmanovici, C | 1 |
| Goormans, E | 1 |
| Grice, G; Kinghorn, GR; Spencer, RC; Steele, CE | 1 |
| Siedentopf, HG | 1 |
| Litschgi, M | 1 |
| Cartwrigth, RY | 1 |
| Benijts, G; Dogniez, B; Ubachs, JM; Wesel, S | 1 |
| Hiltl, BP; Münnich, W | 1 |
| Loendersloot, EW | 1 |
| Raab, W | 1 |
3 review(s) available for terconazole and Candidiasis, Vulvovaginal
| Article | Year |
|---|---|
Treatment of recurrent vulvovaginal candidiasis.
Topics: Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Clotrimazole; Drug Interactions; Female; Fluconazole; Humans; Ketoconazole; Patient Education as Topic; Recurrence; Risk Factors; Teaching Materials; Time Factors; Triazoles | 2000 |
Evolving pathogens in vulvovaginal candidiasis: implications for patient care.
Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Female; Humans; Nonprescription Drugs; Ointments; Recurrence; Risk Factors; Species Specificity; Suppositories; Triazoles | 1992 |
Drugs for treatment of vulvovaginal candidiasis: comparative efficacy of agents and regimens.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Costs and Cost Analysis; Female; Humans; Imidazoles; Miconazole; Pregnancy; Pregnancy Complications, Infectious; Triazoles | 1990 |
15 trial(s) available for terconazole and Candidiasis, Vulvovaginal
| Article | Year |
|---|---|
A randomized clinical trial of the efficacy and safety of terconazole vaginal suppository versus oral fluconazole for treating severe vulvovaginal candidiasis.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Case-Control Studies; China; Drug-Related Side Effects and Adverse Reactions; Female; Fluconazole; Humans; Middle Aged; Prospective Studies; Suppositories; Treatment Outcome; Triazoles; Young Adult | 2015 |
Prevention of recurrent vaginal candidiasis with weekly terconazole cream.
Topics: Adult; Candidiasis, Vulvovaginal; Drug Administration Schedule; Female; Humans; Time Factors; Triazoles; Vaginal Creams, Foams, and Jellies | 1996 |
[Effectiveness and safety of ciclopirox olamine 1% vaginal cream versus terconazole 0.8% vaginal cream in the treatment of genital candidiasis].
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Ciclopirox; Female; Humans; Pyridones; Triazoles; Vaginal Creams, Foams, and Jellies | 2000 |
Single dose oral fluconazole vs intravaginal terconazole in treatment of Candida vaginitis. Comparison and pilot study.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Double-Blind Method; Female; Fluconazole; Follow-Up Studies; Humans; Middle Aged; Pilot Projects; Placebos; Suppositories; Tablets; Time Factors; Triazoles | 1992 |
Terconazole and miconazole cream for treating vulvovaginal candidiasis. A comparison.
Topics: Administration, Intravaginal; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Double-Blind Method; Female; Humans; Miconazole; Middle Aged; Recurrence; Triazoles | 1991 |
[Terconazol in vaginal candidiasis. Comparative study].
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Triazoles | 1990 |
[Terconazole in vaginal candidiasis. A comparative study].
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Triazoles | 1990 |
Terconazole for the treatment of vulvovaginal candidiasis.
Topics: Administration, Intravaginal; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Double-Blind Method; Female; Humans; Miconazole; Suppositories; Triazoles | 1990 |
Comparison of 0.8% and 1.6% terconazole cream in severe vulvovaginal candidiasis.
Topics: Administration, Intravaginal; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Chemistry, Pharmaceutical; Double-Blind Method; Female; Humans; Middle Aged; Random Allocation; Triazoles; Vaginal Creams, Foams, and Jellies | 1990 |
Comparison of terconazole and clotrimazole vaginal tablets in the treatment of vulvovaginal candidosis.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Drug Administration Schedule; Female; Humans; Imidazoles; Random Allocation; Tablets; Triazoles; Vagina | 1986 |
Summary of clinical studies with vaginal formulations of terconazole.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Female; Humans; Suppositories; Triazoles; Vaginal Creams, Foams, and Jellies | 1985 |
Advantages of a 6- to 7-day treatment with 40-mg vaginal suppositories of terconazole against vaginal candidosis: conclusions drawn from a phase II multicentre study in France.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Female; Humans; Recurrence; Suppositories; Time Factors; Triazoles; Vagina | 1985 |
Treatment of vaginal candidosis with three 80-mg terconazole vaginal suppositories: results of a multicentre study in France.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Double-Blind Method; Female; France; Humans; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Suppositories; Triazoles | 1985 |
Comparative double-blind evaluation of the efficacy and tolerability of terconazole 240-mg suppository (1 day) and 80-mg suppositories (3 days) versus clotrimazole 200-mg (3 days) in pregnant patients with vulvovaginal candidosis.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Double-Blind Method; Female; Humans; Imidazoles; Pregnancy; Pregnancy Complications, Infectious; Suppositories; Tablets; Triazoles; Vagina | 1985 |
One-day treatment of vaginal candidosis: comparison of terconazole 240-mg suppository with clotrimazole 500-mg vaginal tablet.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; Humans; Imidazoles; Suppositories; Tablets; Triazoles; Vagina | 1985 |
17 other study(ies) available for terconazole and Candidiasis, Vulvovaginal
| Article | Year |
|---|---|
Antimycotic azoles. 6. Synthesis and antifungal properties of terconazole, a novel triazole ketal.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Dermatomycoses; Female; Guinea Pigs; Rats; Triazoles | 1983 |
Terconazole - a new broad-spectrum antifungal.
Topics: Administration, Oral; Animals; Antifungal Agents; Candidiasis; Candidiasis, Cutaneous; Candidiasis, Vulvovaginal; Dermatomycoses; Dose-Response Relationship, Drug; Female; Fungi; Guinea Pigs; Male; Mice; Rats; Rats, Inbred Strains; Triazoles; Trichomonas Vaginitis; Turkeys; Yeasts | 1983 |
Fatal toxic epidermal necrolysis associated with use of terconazole vaginal suppository.
Topics: Administration, Intravaginal; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Fatal Outcome; Female; Humans; Multiple Organ Failure; Stevens-Johnson Syndrome; Triazoles | 1998 |
Terconazole cream for non-Candida albicans fungal vaginitis: results of a retrospective analysis.
Topics: Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Female; Flucytosine; Humans; Middle Aged; Retrospective Studies; Treatment Outcome; Triazoles; Vaginal Creams, Foams, and Jellies | 2000 |
The in vitro activity of terconazole against yeasts: its topical long-acting therapeutic efficacy in experimental vaginal candidiasis in rats.
Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Clotrimazole; Econazole; Female; Miconazole; Microbial Sensitivity Tests; Nystatin; Rats; Rats, Inbred Strains; Triazoles | 1991 |
[Therapy of mycotic colpitis with terconazole (Gyno-Terazol)].
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Triazoles | 1990 |
Influenza-like syndrome after terconazole.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Drug Hypersensitivity; Female; Humans; Middle Aged; Triazoles | 1988 |
Terconazole for Candida vaginitis.
Topics: Administration, Intravaginal; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Suppositories; Triazoles; Vaginal Creams, Foams, and Jellies | 1988 |
Antifungals in gynaecology: focus on terconazole. International workshop, Frankfurt a.M., September 29, 1984.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Triazoles | 1985 |
Antifungals in gynaecology: focus on terconazole. Rationale for single-dose therapy.
Topics: Candidiasis, Vulvovaginal; Drug Administration Schedule; Female; Humans; Pregnancy; Triazoles | 1985 |
Terconazole 0.8% vaginal cream (5 days) versus clotrimazole 1% (6 days): efficacy and tolerability in an open study.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidazoles; Triazoles; Vaginal Creams, Foams, and Jellies | 1985 |
Assessment of clinical efficacy and tolerability of terconazole 240-mg vaginal suppositories.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Suppositories; Triazoles; Vagina | 1985 |
Terconazole, a new triazole antifungal agent.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Chemical Phenomena; Chemistry; Female; Fungi; Humans; In Vitro Techniques; Pregnancy; Triazoles | 1985 |
Comparative open evaluation of efficacy and tolerability of terconazole 0.8% cream in a 5-day regimen versus clotrimazole 100-mg tablets in a 6-day regimen.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidazoles; Middle Aged; Suppositories; Tablets; Triazoles; Vagina | 1985 |
Single-day topical treatment of vaginal candidosis: an open evaluation of terconazole 240-mg vaginal suppositories versus isoconazole tablets 600 mg.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Miconazole; Suppositories; Tablets; Triazoles; Vagina | 1985 |
Demonstration of effectiveness and tolerability of terconazole 80-mg vaginal suppositories (3 days) versus terconazole 240-mg vaginal suppositories (1 day) versus clotrimazole 200-mg vaginal tablets (3 days) in non-pregnant women with vulvovaginal candido
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidazoles; Suppositories; Tablets; Triazoles; Vagina | 1985 |
[Terconazole, a new triazole derivative for the treatment of vaginal mycoses].
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Triazoles | 1985 |